Report Detail
Global Diabetic Gastroparesis Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029
- RnM4529153 |
- 13 April, 2023 |
- Global |
- 88 Pages |
- GIR (Global Info Research) |
- Other
Diabetic gastroparesis refers to cases of the digestive condition gastroparesis that diabetes causes.
During normal digestion, the stomach contracts to help break down food and move it into the small intestine. Gastroparesis disrupts the stomach’s contraction, which can interrupt digestion. Diabetes can cause gastroparesis due to its effects on the nervous system.
Both type 1 diabetes and type 2 diabetes can cause nerve damage. One of the nerves diabetes may damage is the vagus nerve. The vagus nerve controls the movement of food through the stomach. When the vagus nerve experiences damage, the muscles in the stomach and other parts of the digestive tract are not able to function properly. When this happens, food cannot move as quickly through the digestive system. Gastroparesis is also known as delayed gastric emptying.
According to our (Global Info Research) latest study, the global Diabetic Gastroparesis Treatment market size was valued at USD 3496.7 million in 2022 and is forecast to a readjusted size of USD 5136.1 million by 2029 with a CAGR of 5.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Market is not concentrated. Sumitomo, Johnson & Johnson, Sanofi are the leaders of the industry, and hold the key technologies and patent, with high-end customers. Top 3 manufacturer accounted for 7.4% market share in 2019.
This report is a detailed and comprehensive analysis for global Diabetic Gastroparesis Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Diabetic Gastroparesis Treatment market size and forecasts, in consumption value ($ Million), 2018-2029
Global Diabetic Gastroparesis Treatment market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Diabetic Gastroparesis Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Diabetic Gastroparesis Treatment market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Diabetic Gastroparesis Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Diabetic Gastroparesis Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sumitomo, Johnson & Johnson, Sanofi, Medtronic and Pfizer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Diabetic Gastroparesis Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Drugs
Surgical Treatment Products
Market segment by Application
Hospital Pharmacies
Private Clinics
Drug Stores
E-Commerce
Market segment by players, this report covers
Sumitomo
Johnson & Johnson
Sanofi
Medtronic
Pfizer
Teva
Boston Scientific
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Diabetic Gastroparesis Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Diabetic Gastroparesis Treatment, with revenue, gross margin and global market share of Diabetic Gastroparesis Treatment from 2018 to 2023.
Chapter 3, the Diabetic Gastroparesis Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Diabetic Gastroparesis Treatment market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Diabetic Gastroparesis Treatment.
Chapter 13, to describe Diabetic Gastroparesis Treatment research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Diabetic Gastroparesis Treatment
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Diabetic Gastroparesis Treatment by Type
- 1.3.1 Overview: Global Diabetic Gastroparesis Treatment Market Size by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Global Diabetic Gastroparesis Treatment Consumption Value Market Share by Type in 2022
- 1.3.3 Drugs
- 1.3.4 Surgical Treatment Products
- 1.4 Global Diabetic Gastroparesis Treatment Market by Application
- 1.4.1 Overview: Global Diabetic Gastroparesis Treatment Market Size by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Hospital Pharmacies
- 1.4.3 Private Clinics
- 1.4.4 Drug Stores
- 1.4.5 E-Commerce
- 1.5 Global Diabetic Gastroparesis Treatment Market Size & Forecast
- 1.6 Global Diabetic Gastroparesis Treatment Market Size and Forecast by Region
- 1.6.1 Global Diabetic Gastroparesis Treatment Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global Diabetic Gastroparesis Treatment Market Size by Region, (2018-2029)
- 1.6.3 North America Diabetic Gastroparesis Treatment Market Size and Prospect (2018-2029)
- 1.6.4 Europe Diabetic Gastroparesis Treatment Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific Diabetic Gastroparesis Treatment Market Size and Prospect (2018-2029)
- 1.6.6 South America Diabetic Gastroparesis Treatment Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa Diabetic Gastroparesis Treatment Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 Sumitomo
- 2.1.1 Sumitomo Details
- 2.1.2 Sumitomo Major Business
- 2.1.3 Sumitomo Diabetic Gastroparesis Treatment Product and Solutions
- 2.1.4 Sumitomo Diabetic Gastroparesis Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Sumitomo Recent Developments and Future Plans
- 2.2 Johnson & Johnson
- 2.2.1 Johnson & Johnson Details
- 2.2.2 Johnson & Johnson Major Business
- 2.2.3 Johnson & Johnson Diabetic Gastroparesis Treatment Product and Solutions
- 2.2.4 Johnson & Johnson Diabetic Gastroparesis Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Johnson & Johnson Recent Developments and Future Plans
- 2.3 Sanofi
- 2.3.1 Sanofi Details
- 2.3.2 Sanofi Major Business
- 2.3.3 Sanofi Diabetic Gastroparesis Treatment Product and Solutions
- 2.3.4 Sanofi Diabetic Gastroparesis Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Sanofi Recent Developments and Future Plans
- 2.4 Medtronic
- 2.4.1 Medtronic Details
- 2.4.2 Medtronic Major Business
- 2.4.3 Medtronic Diabetic Gastroparesis Treatment Product and Solutions
- 2.4.4 Medtronic Diabetic Gastroparesis Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Medtronic Recent Developments and Future Plans
- 2.5 Pfizer
- 2.5.1 Pfizer Details
- 2.5.2 Pfizer Major Business
- 2.5.3 Pfizer Diabetic Gastroparesis Treatment Product and Solutions
- 2.5.4 Pfizer Diabetic Gastroparesis Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Pfizer Recent Developments and Future Plans
- 2.6 Teva
- 2.6.1 Teva Details
- 2.6.2 Teva Major Business
- 2.6.3 Teva Diabetic Gastroparesis Treatment Product and Solutions
- 2.6.4 Teva Diabetic Gastroparesis Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Teva Recent Developments and Future Plans
- 2.7 Boston Scientific
- 2.7.1 Boston Scientific Details
- 2.7.2 Boston Scientific Major Business
- 2.7.3 Boston Scientific Diabetic Gastroparesis Treatment Product and Solutions
- 2.7.4 Boston Scientific Diabetic Gastroparesis Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Boston Scientific Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Diabetic Gastroparesis Treatment Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of Diabetic Gastroparesis Treatment by Company Revenue
- 3.2.2 Top 3 Diabetic Gastroparesis Treatment Players Market Share in 2022
- 3.2.3 Top 6 Diabetic Gastroparesis Treatment Players Market Share in 2022
- 3.3 Diabetic Gastroparesis Treatment Market: Overall Company Footprint Analysis
- 3.3.1 Diabetic Gastroparesis Treatment Market: Region Footprint
- 3.3.2 Diabetic Gastroparesis Treatment Market: Company Product Type Footprint
- 3.3.3 Diabetic Gastroparesis Treatment Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Diabetic Gastroparesis Treatment Consumption Value and Market Share by Type (2018-2023)
- 4.2 Global Diabetic Gastroparesis Treatment Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
- 5.1 Global Diabetic Gastroparesis Treatment Consumption Value Market Share by Application (2018-2023)
- 5.2 Global Diabetic Gastroparesis Treatment Market Forecast by Application (2024-2029)
6 North America
- 6.1 North America Diabetic Gastroparesis Treatment Consumption Value by Type (2018-2029)
- 6.2 North America Diabetic Gastroparesis Treatment Consumption Value by Application (2018-2029)
- 6.3 North America Diabetic Gastroparesis Treatment Market Size by Country
- 6.3.1 North America Diabetic Gastroparesis Treatment Consumption Value by Country (2018-2029)
- 6.3.2 United States Diabetic Gastroparesis Treatment Market Size and Forecast (2018-2029)
- 6.3.3 Canada Diabetic Gastroparesis Treatment Market Size and Forecast (2018-2029)
- 6.3.4 Mexico Diabetic Gastroparesis Treatment Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe Diabetic Gastroparesis Treatment Consumption Value by Type (2018-2029)
- 7.2 Europe Diabetic Gastroparesis Treatment Consumption Value by Application (2018-2029)
- 7.3 Europe Diabetic Gastroparesis Treatment Market Size by Country
- 7.3.1 Europe Diabetic Gastroparesis Treatment Consumption Value by Country (2018-2029)
- 7.3.2 Germany Diabetic Gastroparesis Treatment Market Size and Forecast (2018-2029)
- 7.3.3 France Diabetic Gastroparesis Treatment Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom Diabetic Gastroparesis Treatment Market Size and Forecast (2018-2029)
- 7.3.5 Russia Diabetic Gastroparesis Treatment Market Size and Forecast (2018-2029)
- 7.3.6 Italy Diabetic Gastroparesis Treatment Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific Diabetic Gastroparesis Treatment Consumption Value by Type (2018-2029)
- 8.2 Asia-Pacific Diabetic Gastroparesis Treatment Consumption Value by Application (2018-2029)
- 8.3 Asia-Pacific Diabetic Gastroparesis Treatment Market Size by Region
- 8.3.1 Asia-Pacific Diabetic Gastroparesis Treatment Consumption Value by Region (2018-2029)
- 8.3.2 China Diabetic Gastroparesis Treatment Market Size and Forecast (2018-2029)
- 8.3.3 Japan Diabetic Gastroparesis Treatment Market Size and Forecast (2018-2029)
- 8.3.4 South Korea Diabetic Gastroparesis Treatment Market Size and Forecast (2018-2029)
- 8.3.5 India Diabetic Gastroparesis Treatment Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia Diabetic Gastroparesis Treatment Market Size and Forecast (2018-2029)
- 8.3.7 Australia Diabetic Gastroparesis Treatment Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America Diabetic Gastroparesis Treatment Consumption Value by Type (2018-2029)
- 9.2 South America Diabetic Gastroparesis Treatment Consumption Value by Application (2018-2029)
- 9.3 South America Diabetic Gastroparesis Treatment Market Size by Country
- 9.3.1 South America Diabetic Gastroparesis Treatment Consumption Value by Country (2018-2029)
- 9.3.2 Brazil Diabetic Gastroparesis Treatment Market Size and Forecast (2018-2029)
- 9.3.3 Argentina Diabetic Gastroparesis Treatment Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa Diabetic Gastroparesis Treatment Consumption Value by Type (2018-2029)
- 10.2 Middle East & Africa Diabetic Gastroparesis Treatment Consumption Value by Application (2018-2029)
- 10.3 Middle East & Africa Diabetic Gastroparesis Treatment Market Size by Country
- 10.3.1 Middle East & Africa Diabetic Gastroparesis Treatment Consumption Value by Country (2018-2029)
- 10.3.2 Turkey Diabetic Gastroparesis Treatment Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia Diabetic Gastroparesis Treatment Market Size and Forecast (2018-2029)
- 10.3.4 UAE Diabetic Gastroparesis Treatment Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 Diabetic Gastroparesis Treatment Market Drivers
- 11.2 Diabetic Gastroparesis Treatment Market Restraints
- 11.3 Diabetic Gastroparesis Treatment Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
- 11.5 Influence of COVID-19 and Russia-Ukraine War
- 11.5.1 Influence of COVID-19
- 11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
- 12.1 Diabetic Gastroparesis Treatment Industry Chain
- 12.2 Diabetic Gastroparesis Treatment Upstream Analysis
- 12.3 Diabetic Gastroparesis Treatment Midstream Analysis
- 12.4 Diabetic Gastroparesis Treatment Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Diabetic Gastroparesis Treatment. Industry analysis & Market Report on Diabetic Gastroparesis Treatment is a syndicated market report, published as Global Diabetic Gastroparesis Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Diabetic Gastroparesis Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
